In some embodiments, the formulation or composition provides a 0.25:1 ratio, or a 0.5:1 ratio, or a 1:1 ratio, or a 1:2 ratio, or a 1:3, or a 1:4 ratio, or a 1:5 ratio, or a 1:7 ratio, or a 1:10 ratio, or a 1: 15 ratio, or a 1:20 ratio of immediate release and extended release formulations or compositions of a first otic agent and second therapeutic agent, respectively
Ingredients: Coenzyme Q-10: 100mg L-Carnitine: 1,000mg What Can I Expect
10.1161/CIRCRESAHA.124.323816 12
Integration with Advanced Technologies: We often combine peptide therapy with our BTL technologies including Emsculpt Neo (for body composition optimization and functional regeneration), Emsella (for pelvic floor health), and Exion (for skin tightening and collagen production), and Exomind (for mental wellness) to enhance results, particularly for patients who are overweight
Complete, uncropped western blot images from figures are provided in Supplementary Fig